The Translational Breast Cancer Research Consortium (TBCRC)
is a collaborative group founded in 2005 to conduct innovative and high-impact clinical trials for breast cancer. The TBCRC consists of 16 research centers, with member personnel representing clinicians, basic scientists, statisticians, and patient advocates. TBCRC trials not only test novel, laboratory-based strategies, but also attempt to understand the underlying cause and biology of breast cancer. Most, if not all, of the TBCRC trials have a specimen submission or tissue banking component. Please click here to view our mission statement.
Patients: Please ask your physician whether or not you qualify for any TBCRC studies (described in the Active Protocols). Participating hospitals are listed under Clinical Sites. Additionally, useful links regarding breast cancer can be found under the Patient Resources section. To obtain more information about the TBCRC or its studies, please contact the TBCRC Program Manager.
Physicians/ Researchers: TBCRC studies and participating institutions are listed under the Active Protocols portion of the website. Clicking on the protocol number will launch you to a NCI webpage describing the study objectives and eligibility criteria. Please contact the TBCRC Program Manager for additional information about the TBCRC, its members, or its studies.